Zohreh Amoozgar

Zohreh Amoozgar

Company: Sanofi

Job title: Principal Scientist & Lab Head


Reprogramming T Cells to Fight Glioblastoma 5:00 pm

Exploiting the preferential accumulation of Tregs in the tumor by therapeutically altering their function Discussing how the phenotype of GBM Tregs allows their selective targeting and reduces immune-related adverse events Pre-clinical data supporting αGITR with PD1 in GBMRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.